Related references
Note: Only part of the references are listed.Reduced-intensity conditioning allogeneic transplantation from unrelated donors:: Evaluation of mycophenolate mofetil plus cyclosporin a as graft-versus-host disease prophylaxis
Jose A. Perez-Simon et al.
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION (2008)
Sustained remissions of high-risk acute myeloid leukemia and myelodysplastic syndrome after reduced-intensity conditioning allogeneic hematopoietic transplantation:: Chronic graft-versus-host disease is the strongest factor improving survival
David Valcarel et al.
JOURNAL OF CLINICAL ONCOLOGY (2008)
Development of human cytomegalovirus-specific T cell immunity during primary infection of pregnant women and its correlation with virus transmission to the fetus
Daniele Lilleri et al.
JOURNAL OF INFECTIOUS DISEASES (2007)
Monitoring of human cytomegalovirus-specific CD4+ and CD8+ T-cell immunity in patients receiving solid organ transplantation
G. Gerna et al.
AMERICAN JOURNAL OF TRANSPLANTATION (2006)
Would monitoring CMV immune responses allow improved control of CMV in stem cell transplant patients
Per Ljungman
JOURNAL OF CLINICAL VIROLOGY (2006)
Influence of the intensity of the conditioning regimen on the characteristics of acute and chronic graft-versus-host disease after allogeneic transplantation
JA Pérez-Simón et al.
BRITISH JOURNAL OF HAEMATOLOGY (2005)
Reduced-intensity conditioning containing low-dose alemtuzumab before allogeneic peripheral blood stem cell transplantation: graft-versus-host disease is decreased but T-cell reconstitution is delayed
A Dodero et al.
EXPERIMENTAL HEMATOLOGY (2005)
Clinical significance of cytomegalovirus (CMV) antigenemia in the prediction and diagnosis of CMV gastrointestinal disease after allogeneic hematopoietic stem cell transplantation
T Mori et al.
BONE MARROW TRANSPLANTATION (2004)
Immune reconstitution to cytomegalovirus after allogeneic hematopoietic stem cell transplantation: impact of host factors, drug therapy, and subclinical reactivation
M Hakki et al.
BLOOD (2003)
Cytomegalovirus antigenemia and outcome of patients treated with pre-emptive ganciclovir: retrospective analysis of 241 consecutive patients undergoing allogeneic hematopoietic stem cell transplantation
M Yanada et al.
BONE MARROW TRANSPLANTATION (2003)
Cytomegalovirus infections in allogeneic stem cell recipients after reduced-intensity or myeloablative conditioning assessed by quantitative PCR and pp65-antigenemia
J Schetelig et al.
BONE MARROW TRANSPLANTATION (2003)
Impact of CD34+ cell dose on the outcome of patients undergoing reduced-intensity-conditioning allogeneic peripheral blood stem cell transplantation
JA Pérez-Simón et al.
BLOOD (2003)
Human cytomegalovirus immediate-early mRNAemia versus pp65 antigenemia for guiding pre-emptive therapy in children and young adults undergoing hematopoietic stem cell transplantation: a prospective, randomized, open-label trial
G Gerna et al.
BLOOD (2003)
A prospective analysis of immune recovery in children following allogeneic transplantation of T-cell-depleted or non-T-cell-depleted hematopoietic cells from HLA-disparate family donors
K Kalwak et al.
TRANSPLANTATION PROCEEDINGS (2003)
Infectious complications following allogeneic HLA-identical sibling transplantation with antithymocyte globulin-based reduced intensity preparative regimen
M Mohty et al.
LEUKEMIA (2003)
Impact of unrelated donor status on the incidence and outcome of cytomegalovirus infections after non-myeloablative allogeneic stem cell transplantation
C Junghanss et al.
BRITISH JOURNAL OF HAEMATOLOGY (2003)
CMV infection following nonmyeloablative allogeneic stem cell transplantation using Campath
RD Bainton et al.
BLOOD (2002)
High incidence of cytomegalovirus infection after nonmyeloablative stem cell transplantation: potential role of Campath-1H in delaying immune reconstitution
S Chakrabarti et al.
BLOOD (2002)
Dose-adjusted preemptive therapy for cytomegalovirus disease based on real-time polymerase chain reaction after allogeneic hematopoietic stem cell transplantation
T Mori et al.
BONE MARROW TRANSPLANTATION (2002)
Definitions of cytomegalovirus infection and disease in transplant recipients
P Ljungman et al.
CLINICAL INFECTIOUS DISEASES (2002)
Allogeneic peripheral blood stem cell transplantation with reduced-intensity conditioning:: results of a prospective multicentre study
R Martino et al.
BRITISH JOURNAL OF HAEMATOLOGY (2001)
Statistical methods for the analysis and presentation of the results of bone marrow transplants. Part 2: Regression modeling
JP Klein et al.
BONE MARROW TRANSPLANTATION (2001)
Qualitative plasma PCR assay (AMPLICOR CMV test) versus pp65 antigenemia assay for monitoring cytomegalovirus viremia and guiding preemptive ganciclovir therapy in allogeneic stem cell transplantation
C Solano et al.
JOURNAL OF CLINICAL MICROBIOLOGY (2001)
Statistical methods for the analysis and presentation of the results of bone marrow transplants. Part I: Unadjusted analysis
JP Klein et al.
BONE MARROW TRANSPLANTATION (2001)
CMV monitoring after peripheral blood stem cell and bone marrow transplantation by pp65 antigen and quantitative PCR
A Schulenburg et al.
BONE MARROW TRANSPLANTATION (2001)
Reduced-intensity conditioning reduces the risk of severe infections after allogeneic peripheral blood stem cell transplantation
R Martino et al.
BONE MARROW TRANSPLANTATION (2001)
Hematopoietic cell transplantation in older patients with hematologic malignancies: replacing high-dose cytotoxic therapy with graft-versus-tumor effects
PA McSweeney et al.
BLOOD (2001)
Direct visualization of cytomegalovirus-specific T-cell reconstitution after allogeneic stem cell transplantation
K Cwynarski et al.
BLOOD (2001)
Virological, clinical, and ophthalmologic features of cytomegalovirus retinitis after hematopoietic stem cell transplantation
F Crippa et al.
CLINICAL INFECTIOUS DISEASES (2001)
Use of CMV transcripts for monitoring of CMV infections in transplant recipients
G Gerna et al.
INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS (2000)
High rate of secondary viral and bacterial infections in patients undergoing allogeneic bone marrow mini-transplantation
M Mohty et al.
BONE MARROW TRANSPLANTATION (2000)
Share Paper
